The National TB Programme (NTP) will from October begin the implementation of a new Multi-Drug Resistance (MDR) treatment regimen for TB care in Ghana. The new World Health Organisation (WHO) Drug Resistant (DR-TB) treatment regimen, Bedaquilin, Protomanid and Moxifloxacin (BPal M) would provide patients with a shorter treatment period of…